Monitoring of Intracellular l-βD-Arabinofuranosylcytosine 5′-Triphosphate in 1-β-D-Arabinofuranosylcytosine Therapy at Low and Conventional Doses-Reference-Cited by-同舟云学术

Monitoring of Intracellular l-βD-Arabinofuranosylcytosine 5′-Triphosphate in 1-β-D-Arabinofuranosylcytosine Therapy at Low and Conventional Doses

Published:2001-05 Issue:5 Volume:92 Page:546-553
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Yamauchi Takahiro,Kawai Yasukazu,Kishi Shinji,Goto Nobuyuki,Urasaki Yoshimasa,Imamura Shin,Fukushima Toshihiro,Yoshida Akira,Iwasaki Hiromichi,Tsutani Hiroshi,Masada Mikio,Ueda Takanori

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2001.tb01128.x/fullpdf

Reference32 articles.

1. Chemotherapy in acute myelogenous leukemia: high dose, higher expectations;Berman;J. Clin. OncoL,1995

2. What is the best induction regimen for acute myelogenous leukemia;Rowe;Leukemia,1998

3. Current situation and perspective for treatment of acute myelogenous leukemia in adults;Fukushima;Jpn. J. Cancer Chemother,1998

4. Treatment of acute myelogenous leukemia in adults with N4-behenoyl-β-D-arabinofuranosylcy-tosine;Kimura;Cancer,1985

5. N4-behenoyl-l-β-D-arabino-furanosylcytosine as a potential new antitumor agent;Aoshima;Cancer Res,1977

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial;Journal of Internal Medicine;2022-08-18

2. Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid;BMC Pharmacology and Toxicology;2015-05-02

3. Simultaneous determination of 1-β-d-Arabinofuranosylcytosine and two metabolites, 1-β-d-Arabinofuranosyluracil and 1-β-d-Arabinofuranosylcytosine triphosphate in leukemic cell by HPLC-MS/MS and the application to cell pharmacokinetics;Journal of Chromatography B;2014-07

4. Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses;International Journal of Oncology;2011-04-01

5. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5′-nucleotidase II expression ratio in primary acute myeloid leukemia cells;Biochemical Pharmacology;2009-06